New scoring methodology improves the sensitivity of the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials

INTRODUCTION: As currently used, the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) has low sensitivity for measuring Alzheimer’s disease progression in clinical trials. A major reason behind the low sensitivity is its sub-optimal scoring methodology, which can be improved to obt...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Alzheimers Res Ther
Hlavní autoři: Verma, Nishant, Beretvas, S. Natasha, Pascual, Belen, Masdeu, Joseph C., Markey, Mia K.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4642693/
https://ncbi.nlm.nih.gov/pubmed/26560146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-015-0151-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky